Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Registration fees for foreign firms?

This article was originally published in The Tan Sheet

Executive Summary

Sen. Chuck Grassley, R-Iowa, urges HHS and FDA to consider the feasibility of registration fees for foreign pharmaceutical drug manufacturers as a way to "augment the FDA's inspection resources and to limit the number of facilities that may register with the FDA without any intention of shipping products to the United States." In a March 11 letter, Grassley, who is ranking member on the Senate Finance Committee, also notes many foreign plants register with FDA as a means to "bolster their own standing and with no intention" of exporting products to the U.S. and this "bogs down the system." He says collecting fees from the estimated 3,000 foreign facilities currently registered with FDA would raise more than $5.1 million for inspections and would limit the number of foreign companies that register. "This amounts to about a 40 percent increase for FDA's current foreign inspection budget of roughly $12.7 million," he says. The senator asks for a written response "as soon as possible" as well as a briefing from HHS/FDA...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS101468

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel